MED · NYSE
MEDIFAST (MED) Stock Price & Fundamentals
MEDIFAST (MED) closed at $918.27 on Oct 9, 2026, up 0.37% from the previous close of $914.87.
Share price, past year
1Y +37.63%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $918.27 |
| Sep 30, 2026 | $907.59 |
| Aug 31, 2026 | $926.70 |
| Jul 31, 2026 | $925.87 |
| Jun 30, 2026 | $856.78 |
| May 29, 2026 | $858.20 |
| Apr 30, 2026 | $825.30 |
| Mar 31, 2026 | $850.22 |
| Feb 27, 2026 | $743.15 |
| Jan 30, 2026 | $750.34 |
| Dec 31, 2025 | $708.87 |
| Nov 28, 2025 | $687.63 |
| Oct 31, 2025 | $677.14 |
Key statistics
- Market cap
- $10.27B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.32
- Revenue (TTM)
- $316.93M
- Net income (TTM)
- −$25.60M
- Shares outstanding
- 11.2M
- Dividend yield
- —
- 52-week range
- $647.68 – $943.48
MEDIFAST's market cap is $10.27B, based on a share price of $918.27 and 11.2M shares outstanding as of Jun 30, 2026.
Financials
MEDIFAST reported revenue of $385.79M for fiscal 2025, down 35.96% from fiscal 2024.
MEDIFAST reported a net loss of $18.67M in fiscal 2025.
MEDIFAST's fiscal 2025 net loss was its first in at least 9 years.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $385.79M | −36.0% | −$18.67M | −4.8% | −$1.70 | $1.25M |
| FY2024ended Dec 31, 2024 | $602.46M | −43.8% | $2.09M | 0.4% | $0.19 | $17.02M |
| FY2023ended Dec 31, 2023 | $1.07B | −32.9% | $99.42M | 9.3% | $9.10 | $141.17M |
| FY2022ended Dec 31, 2022 | $1.60B | +4.8% | $143.57M | 9.0% | $12.73 | $177.89M |
| FY2021ended Dec 31, 2021 | $1.53B | +63.3% | $164.03M | 10.8% | $13.89 | $60.34M |
| FY2020ended Dec 31, 2020 | $934.84M | +31.0% | $102.86M | 11.0% | $8.68 | $139.31M |
| FY2019ended Dec 31, 2019 | $713.67M | +42.5% | $77.92M | 10.9% | $6.43 | $74.20M |
| FY2018ended Dec 31, 2018 | $501.00M | +66.1% | $55.79M | 11.1% | $4.62 | $55.88M |
| FY2017ended Dec 31, 2017 | $301.56M | +9.9% | $27.72M | 9.2% | $2.29 | $40.00M |
| FY2016ended Dec 31, 2016 | $274.53M | — | $17.84M | 6.5% | $1.49 | $22.47M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $76.38M | −$3.10M | −$0.28 |
| Q1 FY2026ended Mar 31, 2026 | $76.04M | −$2.12M | −$0.19 |
| Q4 FY2025ended Dec 31, 2025 | $75.10M | −$18.12M | −$1.64 |
| Q3 FY2025ended Sep 30, 2025 | $89.41M | −$2.26M | −$0.21 |
| Q2 FY2025ended Jun 30, 2025 | $105.56M | $2.48M | $0.22 |
| Q1 FY2025ended Mar 31, 2025 | $115.73M | −$772.00K | −$0.07 |
| Q4 FY2024ended Dec 31, 2024 | $119.00M | $800.00K | $0.08 |
| Q3 FY2024ended Sep 30, 2024 | $140.16M | $1.13M | $0.10 |
Company profile
- Name
- MEDIFAST INC
- Ticker
- MED
- Exchange
- NYSE
- Industry (SEC SIC)
- Miscellaneous Food Preparations & Kindred Products
- Headquarters
- 1501 S. Clinton Street, Suite 500, Baltimore, MD 21224
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000910329
Recent SEC filings
- Aug 3, 2026
- Aug 3, 2026
- Jul 17, 2026
- Jun 1, 2026
- May 26, 2026
- May 4, 2026
- May 4, 2026
- Mar 20, 2026
Frequently asked questions
What is MEDIFAST's stock price?
MEDIFAST (MED) closed at $918.27 on Oct 9, 2026, up 0.37% from the previous close of $914.87.
What is MEDIFAST's market cap?
MEDIFAST's market cap is $10.27B, based on a share price of $918.27 and 11.2M shares outstanding as of Jun 30, 2026.
How much revenue does MEDIFAST make?
MEDIFAST reported revenue of $385.79M for fiscal 2025, down 35.96% from fiscal 2024.
Does MEDIFAST pay a dividend?
Yes. MEDIFAST declared $0.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from MEDIFAST INC's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures